Latest Series B Funding Rounds
Startups financing expansion after their early institutional rounds. Explore the businesses, round sizes and investors behind the next phase.
- Rounds
- 465 All time
- Disclosed funding
- $36.1B 412 disclosed amounts
- Median round
- $45.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| MT Metagen TherapeuticsCompany profile A clinical-stage biotechnology company developing microbiome-based therapies using fecal microbiota transplantation. A clinical-stage biotechnology company developing microbiome-based therapies using fecal microbiota transplantation. | ¥190M | Series B extension (first close)Series B | Biotech | Japan | Investors | |
| C CometCompany profile Comet is a digital-first footwear brand that designs and sells its own sneakers and casual shoes to Indian consumers. Comet is a digital-first footwear brand that designs and sells its own sneakers and casual shoes to Indian consumers. | ~₹1B | Series B | Consumer | India | Investors | |
| H HiddenLayerCompany profile HiddenLayer sells cybersecurity software built specifically to protect AI models, agents and applications. Its platform discovers AI assets, scans models and their supply chains, tests for adversarial attacks and monitors deployed systems for threats across the AI development and operating lifecycle. HiddenLayer sells cybersecurity software built specifically to protect AI models, agents and applications. Its platform discovers AI assets, scans models and their supply chains, tests for adversarial attacks and monitors deployed systems for threats across the AI development and operating lifecycle. | $100M | Series B | Cybersecurity | United States | Investors | |
| SM Superluminal MedicinesCompany profile Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity. Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity. | $60M | Series B | Biotech | United States | Investors | |
| MB Medici BrandsCompany profile Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient. | $250M | Series B | Foodtech | United States | Investors | |
| NM N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
| T TabaPayCompany profile TabaPay provides a unified API for businesses to accept payments and move funds instantly across cards, bank accounts and payment networks. Fintechs, lenders and other platforms use it to collect money and send payouts through the rails their customers can access. TabaPay provides a unified API for businesses to accept payments and move funds instantly across cards, bank accounts and payment networks. Fintechs, lenders and other platforms use it to collect money and send payouts through the rails their customers can access. | $155M | Series B strategic growth financingSeries B | Fintech | United States | Investors | |
| M MetroWeatherCompany profile A sensing company developing lidar systems for three-dimensional wind measurement and aerial-object detection. A sensing company developing lidar systems for three-dimensional wind measurement and aerial-object detection. | ¥1.5B | Series B first closeSeries B | Defense tech | Japan | Investors | |
| i iPRONICSCompany profile iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks. iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks. | $125M | Series B | Hardware | Spain | Investors | |
| NT NovaGo TherapeuticsCompany profile NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury. NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury. | CHF 24M | Series B | Biotech | Switzerland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Greptile, Nous Research, Firecrawl
19rounds0led - 2Andreessen Horowitz (a16z)
Town, Arena, Vesta
18rounds3led - 3Khosla Ventures
Even Healthcare, Arena, Vinci
18rounds3led - 4Accel
RapidCanvas, Armadin, Ema
14rounds1led - 5General Catalyst
Evvy, Faro AI, Senra Systems
14rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.